These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 4859626)

  • 1. Serological survey for rubella and measles antibodies among first graders.
    Schiff GM; Linnemann CC; Shea L; Witte JJ; Ackerman JH; Stapleton L; Elsea WR; Agna M
    JAMA; 1974 Jan; 227(1):49-52. PubMed ID: 4859626
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recognition and immunoprophylaxis of measles and rubella].
    Zhang B; Ma L
    Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):698-700. PubMed ID: 32842396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined trivalent and bivalent measles, mumps and rubella virus vaccination. A controlled trial.
    Swartz TA; Klingberg W; Klingberg MA
    Infection; 1974; 2(3):115-7. PubMed ID: 4606362
    [No Abstract]   [Full Text] [Related]  

  • 4. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
    Krober MS; Stracener CE; Bass JW
    JAMA; 1991 Apr; 265(16):2095-6. PubMed ID: 2013930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies against measles, mumps and rubella in Israeli young adults.
    Danon YL; Adir Y; Abend I; Zaaide Y; Green MS
    Isr J Med Sci; 1992 Oct; 28(10):733-6. PubMed ID: 1399506
    [No Abstract]   [Full Text] [Related]  

  • 7. Present status of measles and rubella immunization in the United States: a medical progress report.
    Krugman S
    J Pediatr; 1977 Jan; 90(1):1-12. PubMed ID: 12253
    [No Abstract]   [Full Text] [Related]  

  • 8. Serological assessment of measles-rubella vaccination catch-up campaign among university students.
    Takeuchi J; Goto M; Kawamura T; Hiraide A
    Pediatr Int; 2014 Jun; 56(3):395-9. PubMed ID: 24417932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
    Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM
    Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
    Pauksen K; Duraj V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Fridell E; Smedmyr B; Simonsson B
    Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up surveillance for antibody in human subjects following live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Proc Soc Exp Biol Med; 1979 Nov; 162(2):328-32. PubMed ID: 515009
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children.
    Sepúlveda-Amor J; Valdespino-Gómez JL; García-García Mde L; Bennett J; Islas-Romero R; Echaniz-Aviles G; de Castro JF
    Vaccine; 2002 Jun; 20(21-22):2790-5. PubMed ID: 12034106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
    Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Safety and efficacy in two-dose vaccination using measles and rubella combined (MR) vaccine].
    Terada K; Ouchi K; Ihara T; Okada K; Numazaki K
    Kansenshogaku Zasshi; 2008 Sep; 82(5):414-8. PubMed ID: 18975583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M; Berger R; Just V
    Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinico-immunological evaluation of a bivalent vaccine against measles and rubella].
    Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
    Minerva Pediatr; 1990 Dec; 42(12):531-6. PubMed ID: 2087226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary study on nasal spray of interferon alpha-2b used for prevention of rubella and measles virus infections].
    Zhao J; Zhu FC; Shu YL; Zhou R; Liu LQ; Zhang LL; Shi ZY; Tang Z; Lin LZ; Yu ZA; Zhang LP; Zhang B; Hou YD
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):220-2. PubMed ID: 16261201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined live measles-rubella virus vaccine. Findings in clinical laboratory studies.
    Villarejos VM; Arguedas JA; Buynak EB; Weibel RE; Stokes J; Hilleman MR
    J Pediatr; 1971 Oct; 79(4):599-604. PubMed ID: 5094254
    [No Abstract]   [Full Text] [Related]  

  • 20. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
    Kremer JR; Schneider F; Muller CP
    Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.